Patent Assignment
Reel/Frame 062699/0981
Corrective Assignment to Correct the Typographical Error in 2ND Inventor's First Name from Balwinger Singh Bhatti to Balwinder Singh Bhatti Previously Recorded on Reel 062066 Frame 0148. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-02-10
Pages: 11
Assignors
AKIREDDY, SRINIVASA RAO
Executed: 2011-05-16
BHATTI, BALWINDER SINGH
Executed: 2011-05-18
CUTHBERTSON, TIMOTHY J.
Executed: 2011-05-16
DULL, GARY MAURICE
Executed: 2011-05-16
MILLER, CRAIG HARRISON
Executed: 2011-06-02
MITCHENER, JOSEPH PIKE, JR.
Executed: 2011-05-16
MUNOZ, JULIO A.
Executed: 2011-05-26
OTTEN, PIETER ALBERT
Executed: 2011-05-18
Assignee
TARGACEPT, INC.
200 EAST FIRST STREET, SUITE 300, WINSTON-SALEM, NORTH CAROLINA, 27101
Covered Property
(1)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application:
18/061,354 →
Publication:
US 2023/0295126
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 5, 2022
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 062065/0807 →
Assignment of Assignor's Interest
Dec 5, 2022
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINGER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 062066/0148 →
Change of Name
Dec 5, 2022
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 062066/0201 →
Release of Security Interest
Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →